153 related articles for article (PubMed ID: 25895132)
1. Combining TGF-β1 knockdown and miR200c administration to optimize antitumor efficacy of B16F10/GPI-IL-21 vaccine.
Wang X; Zhao F; He X; Wang J; Zhang Y; Zhang H; Ni Y; Sun J; Wang X; Dou J
Oncotarget; 2015 May; 6(14):12493-504. PubMed ID: 25895132
[TBL] [Abstract][Full Text] [Related]
2. Reinforcing B16F10/GPI-IL-21 vaccine efficacy against melanoma by injecting mice with shZEB1 plasmid or miR200c agomir.
Wang X; Zhao F; Shi F; He X; Pan M; Wu D; Li M; Zhang Y; Dou J
Biomed Pharmacother; 2016 May; 80():136-144. PubMed ID: 27133050
[TBL] [Abstract][Full Text] [Related]
3. Regulation gene expression of miR200c and ZEB1 positively enhances effect of tumor vaccine B16F10/GPI-IL-21 on inhibition of melanoma growth and metastasis.
Wang X; He X; Zhao F; Wang J; Zhang H; Shi F; Zhang Y; Cai K; Dou J
J Transl Med; 2014 Mar; 12():68. PubMed ID: 24625224
[TBL] [Abstract][Full Text] [Related]
4. [Preliminary study of the inhibitory effect and mechanism of B16F10-ESAT-6-gpi/IL-21 vaccine on the pulmonary metastasis in mouse models of melanoma].
He X; Shi W; Zhao F; Wang J; Xu X; Tan Q; Sun Y; Chen D; Dou J
Zhonghua Zhong Liu Za Zhi; 2014 Apr; 36(4):245-9. PubMed ID: 24989908
[TBL] [Abstract][Full Text] [Related]
5. Stereospecific effects of ginsenoside 20-Rg3 inhibits TGF-β1-induced epithelial-mesenchymal transition and suppresses lung cancer migration, invasion and anoikis resistance.
Kim YJ; Choi WI; Jeon BN; Choi KC; Kim K; Kim TJ; Ham J; Jang HJ; Kang KS; Ko H
Toxicology; 2014 Aug; 322():23-33. PubMed ID: 24793912
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-23 and interleukin-27 exert quite different antitumor and vaccine effects on poorly immunogenic melanoma.
Oniki S; Nagai H; Horikawa T; Furukawa J; Belladonna ML; Yoshimoto T; Hara I; Nishigori C
Cancer Res; 2006 Jun; 66(12):6395-404. PubMed ID: 16778218
[TBL] [Abstract][Full Text] [Related]
7. Enhancing therapy of B16F10 melanoma efficacy through tumor vaccine expressing GPI-anchored IL-21 and secreting GM-CSF in mouse model.
Zhao F; Dou J; He XF; Wang J; Chu L; Hu W; Yu F; Hu K; Wu Y; Gu N
Vaccine; 2010 Apr; 28(16):2846-52. PubMed ID: 20153795
[TBL] [Abstract][Full Text] [Related]
8. Investigation on the anti-tumor efficacy by expression of GPI-anchored mIL-21 on the surface of B16F10 cells in C57BL/6 mice.
Zhao F; Dou J; Wang J; Chu L; Tang Q; Wang Y; Li Y; Cao M; Hu W; Hu K; Feng He X; Gu N
Immunobiology; 2010; 215(2):89-100. PubMed ID: 19457579
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
[TBL] [Abstract][Full Text] [Related]
10. Curcumin reverses the epithelial-mesenchymal transition of pancreatic cancer cells by inhibiting the Hedgehog signaling pathway.
Sun XD; Liu XE; Huang DS
Oncol Rep; 2013 Jun; 29(6):2401-7. PubMed ID: 23563640
[TBL] [Abstract][Full Text] [Related]
11. Suppression of the production of transforming growth factor β1, interleukin-10, and vascular endothelial growth factor in the B16F10 cells by Ganoderma lucidum polysaccharides.
Sun LX; Lin ZB; Duan XS; Qi HH; Yang N; Li M; Xing EH; Sun Y; Yu M; Li WD; Lu J
J Interferon Cytokine Res; 2014 Sep; 34(9):667-75. PubMed ID: 24673200
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-β 1 enhances the invasiveness of breast cancer cells by inducing a Smad2-dependent epithelial-to-mesenchymal transition.
Lv ZD; Kong B; Li JG; Qu HL; Wang XG; Cao WH; Liu XY; Wang Y; Yang ZC; Xu HM; Wang HB
Oncol Rep; 2013 Jan; 29(1):219-25. PubMed ID: 23129177
[TBL] [Abstract][Full Text] [Related]
13. Ganoderma lucidum polysaccharides antagonize the suppression on lymphocytes induced by culture supernatants of B16F10 melanoma cells.
Sun LX; Lin ZB; Duan XS; Lu J; Ge ZH; Li XJ; Li M; Xing EH; Jia J; Lan TF; Li WD
J Pharm Pharmacol; 2011 May; 63(5):725-35. PubMed ID: 21492175
[TBL] [Abstract][Full Text] [Related]
14. Using adenovirus armed short hairpin RNA targeting transforming growth factor β1 inhibits melanoma growth and metastasis in an ex vivo animal model.
Tai KF; Wang CH
Ann Plast Surg; 2013 Dec; 71 Suppl 1():S75-81. PubMed ID: 24284745
[TBL] [Abstract][Full Text] [Related]
15. ESAT-6-gpi DNA vaccine augmented the specific antitumour efficacy induced by the tumour vaccine B16F10-ESAT-6-gpi/IL-21 in a mouse model.
He X; Wang J; Zhao F; Chen D; Chen J; Zhang H; Yang C; Liu Y; Dou J
Scand J Immunol; 2013 Jul; 78(1):69-78. PubMed ID: 23679337
[TBL] [Abstract][Full Text] [Related]
16. Ahnak promotes tumor metastasis through transforming growth factor-β-mediated epithelial-mesenchymal transition.
Sohn M; Shin S; Yoo JY; Goh Y; Lee IH; Bae YS
Sci Rep; 2018 Sep; 8(1):14379. PubMed ID: 30258109
[TBL] [Abstract][Full Text] [Related]
17. Antitumor efficacy of viable tumor vaccine modified by heterogenetic ESAT-6 antigen and cytokine IL-21 in melanomatous mouse.
He X; Wang J; Zhao F; Yu F; Chen D; Cai K; Yang C; Chen J; Dou J
Immunol Res; 2012 Jun; 52(3):240-9. PubMed ID: 22477528
[TBL] [Abstract][Full Text] [Related]
18. Enhanced efficacy of combination of IL-2 gene and IL-6 gene-transfected tumor cells in the treatment of established metastatic tumors.
Cao X; Chen C; Zhang W; Tao Q; Yu Y; Ye T
Gene Ther; 1996 May; 3(5):421-6. PubMed ID: 9156803
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-β and epithelial-mesenchymal transition are associated with pulmonary metastasis in adenoid cystic carcinoma.
Dong L; Ge XY; Wang YX; Yang LQ; Li SL; Yu GY; Gao Y; Fu J
Oral Oncol; 2013 Nov; 49(11):1051-8. PubMed ID: 23962790
[TBL] [Abstract][Full Text] [Related]
20. Gene therapy with interleukin-10 receptor and interleukin-12 induces a protective interferon-γ-dependent response against B16F10-Nex2 melanoma.
Marchi LH; Paschoalin T; Travassos LR; Rodrigues EG
Cancer Gene Ther; 2011 Feb; 18(2):110-22. PubMed ID: 20885448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
